Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Canadian Sec - Delayed Quote CAD

Ovation Science Inc. (OVAT.CN)

Compare
0.0250
0.0000
(0.00%)
At close: February 19 at 1:09:45 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
NameTitlePayExercisedYear Born
Mr. Terry H. Howlett President, CEO & Director 114.75k -- 1948
Ms. Doreen McMorran CFO, VP, COO & Director 91.8k -- 1962

Ovation Science Inc.

1166 Alberni Street
Suite 1003
Vancouver, BC V6E 3Z3
Canada
604 982 5700 https://ovationscience.com
Sector: 
Healthcare

Description

Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States. The company sublicenses product formulations through Invisicare, a patented drug delivery technology to produce topical and transdermal cannabis products under the Ovation name. It also offers cannabidiol health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil. Ovation Science Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada. Ovation Science Inc. operates as a subsidiary of Skinvisible Pharmaceuticals, Inc.

Corporate Governance

Ovation Science Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events